GB Sciences, Inc. (OTCMKTS:GBLX) Sees Significant Decline in Short Interest

GB Sciences, Inc. (OTCMKTS:GBLX) was the recipient of a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 900 shares, a drop of 10.0% from the March 31st total of 1,000 shares. Based on an average daily trading volume, of 218,100 shares, the short-interest ratio is presently 0.0 days.

GB Sciences Stock Performance

OTCMKTS GBLX opened at $0.01 on Wednesday. GB Sciences has a one year low of $0.01 and a one year high of $0.02. The company’s 50 day moving average price is $0.01 and its 200 day moving average price is $0.01.

GB Sciences Company Profile

GB Sciences, Inc, a phytomedical research and biopharmaceutical drug development company, engages in the research and development of plant-based medicines. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs.